187 related articles for article (PubMed ID: 24566016)
1. Computed tomography or magnetic resonance imaging - our experiences in determining preoperative TNM staging of bladder cancer.
Stojovska-Jovanovska E; Mitreska N; Stojovski M; Lazarova A; Stavridis S; Dodevski A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):63-70. PubMed ID: 24566016
[TBL] [Abstract][Full Text] [Related]
2. Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol.
Liedberg F; Bendahl PO; Davidsson T; Gudjonsson S; Holmer M; Månsson W; Wallengren NO
Scand J Urol; 2013 Apr; 47(2):108-12. PubMed ID: 22989110
[TBL] [Abstract][Full Text] [Related]
3. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
[TBL] [Abstract][Full Text] [Related]
4. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
Kim B; Semelka RC; Ascher SM; Chalpin DB; Carroll PR; Hricak H
Radiology; 1994 Oct; 193(1):239-45. PubMed ID: 8090898
[TBL] [Abstract][Full Text] [Related]
5. Urinary bladder cancer: role of MR imaging.
Verma S; Rajesh A; Prasad SR; Gaitonde K; Lall CG; Mouraviev V; Aeron G; Bracken RB; Sandrasegaran K
Radiographics; 2012; 32(2):371-87. PubMed ID: 22411938
[TBL] [Abstract][Full Text] [Related]
6. Preoperative imaging for staging bladder cancer.
McKibben MJ; Woods ME
Curr Urol Rep; 2015 Apr; 16(4):22. PubMed ID: 25724433
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
[TBL] [Abstract][Full Text] [Related]
8. Dynamic MRI of bladder cancer: evaluation of staging accuracy.
Tekes A; Kamel I; Imam K; Szarf G; Schoenberg M; Nasir K; Thompson R; Bluemke D
AJR Am J Roentgenol; 2005 Jan; 184(1):121-7. PubMed ID: 15615961
[TBL] [Abstract][Full Text] [Related]
9. Value of MRI in local staging of bladder cancer.
Ghafoori M; Shakiba M; Ghiasi A; Asvadi N; Hosseini K; Alavi M
Urol J; 2013; 10(2):866-72. PubMed ID: 23801469
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of gadolinium-diethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder: a comparative study with computerized tomography and transurethral ultrasonography.
Tachibana M; Baba S; Deguchi N; Jitsukawa S; Hata M; Tazaki H; Tanimoto A; Yuasa Y; Hiramatsu K
J Urol; 1991 Jun; 145(6):1169-73. PubMed ID: 2033686
[TBL] [Abstract][Full Text] [Related]
11. State-of-the-art cross-sectional imaging in bladder cancer.
Setty BN; Holalkere NS; Sahani DV; Uppot RN; Harisinghani M; Blake MA
Curr Probl Diagn Radiol; 2007; 36(2):83-96. PubMed ID: 17331839
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
Lista F; Andrés G; Cáceres F; Ramón de Fata F; Rodríguez-Barbero JM; Angulo JC
Actas Urol Esp; 2013; 37(7):419-24. PubMed ID: 23773823
[TBL] [Abstract][Full Text] [Related]
13. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
14. [Can MRI be used to distinguish between superficial and invasive transitional cell bladder cancer?].
Tillou X; Grardel E; Fourmarier M; Bernasconi T; Demailly M; Hakami F; Saint F; Petit J
Prog Urol; 2008 Jul; 18(7):440-4. PubMed ID: 18602604
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging.
Barentsz JO; Berger-Hartog O; Witjes JA; Hulsbergen-van der Kaa C; Oosterhof GO; VanderLaak JA; Kondacki H; Ruijs SH
Radiology; 1998 Jun; 207(3):791-7. PubMed ID: 9609906
[TBL] [Abstract][Full Text] [Related]
16. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
17. [Staging of urinary bladder tumors with CT and MRI].
Akmangit I; Lakadamyali H; Oto A; Ozen H; Akhan O; Besim A
Tani Girisim Radyol; 2003 Mar; 9(1):63-9. PubMed ID: 14661295
[TBL] [Abstract][Full Text] [Related]
18. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy.
Paik ML; Scolieri MJ; Brown SL; Spirnak JP; Resnick MI
J Urol; 2000 Jun; 163(6):1693-6. PubMed ID: 10799162
[TBL] [Abstract][Full Text] [Related]
19. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
Kollberg P; Almquist H; Bläckberg M; Cronberg C; Garpered S; Gudjonsson S; Kleist J; Lyttkens K; Patschan O; Liedberg F
Scand J Urol; 2015; 49(4):296-301. PubMed ID: 25623843
[TBL] [Abstract][Full Text] [Related]
20. [Staging urinary bladder cancer with dynamic MR imaging].
Tsuda K; Narumi Y; Nakamura H; Nonomura I; Okuyama A
Hinyokika Kiyo; 2000 Nov; 46(11):835-9. PubMed ID: 11193308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
